Article
Targeting CXCR1 and CXCR2 to overcome radiotherapy resistance in PTEN-deficient prostate…
medRxiv · 2020 · Armstrong, C. W. D.; Coulter, J. A.; Ong, C. W.; Maxwell, P. J.; Walker, S.; Butterworth, K. T.; Lyubomska, O.; Berlingeri, S.; Gallagher, R.; O'Sullivan, J. M.; Jain, S.; Mills, I. G.; Prise, K. M.; Bristow, R. G.; LaBonte, M. J.; Waugh, D. J. J.
Key facts
| Title | Targeting CXCR1 and CXCR2 to overcome radiotherapy resistance in PTEN-deficient prostate carcinoma |
|---|---|
| First author | Armstrong, C. W. D.; Coulter, J. A.; Ong, C. W.; Maxwell, P. J.; Walker, S.; Butterworth, K. T.; Lyubomska, O.; Berlingeri, S.; Gallagher, R.; O'Sullivan, J. M.; Jain, S.; Mills, I. G.; Prise, K. M.; Bristow, R. G.; LaBonte, M. J.; Waugh, D. J. J. |
| Journal | medRxiv |
| Published | Mar 16, 2020 |
| DOI | 10.1101/2020.03.16.993394 |
| Devices mentioned | BK110039 |
| Product codes mentioned | KIT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1